Emad Rakha:

Molecular Diagnostics In Breast Cancers 

Prof Rakha is a Professor and Honorary Consultant Pathologist at the University of Nottingham (UoN) and Nottingham University Hospitals NHS Trust, Nottingham, UK.


His main clinical disciplines are Breast Pathology. Prof Rakha is medically qualified and gained master (MSc pathology) and MD in Pathology (by examination), PhD in molecular pathology (Breast cancer) from UoN and obtained the Fellowship of the Royal College of Pathologists by examination. He is a leading member of the multi-disciplinary Nottingham Breast Research Group at UoN. As part of his clinical commitment, he works as a co-lead of the Trust core-facility Biorepository (Nottingham Health Science Biobank). He is a member of The National Coordinating Committee of Breast Pathology (BIG18), the Pathological Society of Great Britain and Ireland Management Committee, NICR Breast CSG Translational Subgroup, Breast Cancer Now Tissue Access Committee, International Society of Breast Pathology, and International Breast Pathology Group. Prof Rakha organises the National Nottingham Breast Pathology Masterclass which is an annual course run in Nottingham, UK and Bologna Italy (http://nottinghambreastpathologymasterclass.com/) and he runs the national and international referral service of breast pathology consultation cases in Nottingham with Professor Ian Ellis.

During the past 10 years he has been co-author on more than 220 peer-reviewed publications (87 first author publications and 27 senior authors) in addition to 28 articles submitted or in preparation and more than 190 abstract submissions to national and international conferences and meetings. He is an author for 25 book chapters in breast disease including the WHO Blue Book and Flecther Diagnostic Histopathology of Tumors new editions. He is acting as a reviewer to 24 indexed and high profile international journals and editor to three journals. He is supervising and co-supervising a number of postgraduate and undergraduate students at UoN, visiting trainees and consultants in breast pathology and molecular pathology and has an extensive network of national and international research collaborators.